There are five tumor necrosis factor-a (TNF-a) inhibitors currently used in Canada in the treatment of rheumatic diseases. These are:
- infliximab (Remicade)
- etanercept (Enbrel)
- adalimumab (Humira)
- golimumab (Simponi)
- certolizumab pegol (Cimzia)
List 4 potential side effects of these drugs.